Department of Speech, Language, and Hearing Sciences, University of Texas at Austin, 2504A Whitis Ave. (A1100), 78712, Austin, TX, USA.
School of Psychology, University of Sydney, 2006, Sydney, NSW, Australia.
Neuropsychol Rev. 2024 Sep;34(3):882-923. doi: 10.1007/s11065-023-09607-1. Epub 2023 Oct 4.
Primary progressive aphasia (PPA) and primary progressive apraxia of speech (PPAOS) are neurodegenerative syndromes characterized by progressive decline in language or speech. There is a growing number of studies investigating speech-language interventions for PPA/PPAOS. An updated systematic evaluation of the treatment evidence is warranted to inform best clinical practice and guide future treatment research. We systematically reviewed the evidence for behavioral treatment for speech and language in this population. Reviewed articles were published in peer-reviewed journals through 31 May 2021. We evaluated level of evidence, reporting quality, and risk of bias using a modified version of the American Speech-Language Hearing Association (ASHA) Levels of Evidence, an appraisal point system, additional reporting quality and internal/external validity items, and, as appropriate, the Single Case Experimental Design Scale or the Physiotherapy Evidence Database - PsycBITE Rating Scale for Randomized and Non-Randomized Controlled Trials. Results were synthesized using quantitative summaries and narrative review. A total of 103 studies reported treatment outcomes for 626 individuals with PPA; no studies used the diagnostic label PPAOS. Most studies evaluated interventions for word retrieval. The highest-quality evidence was provided by 45 experimental and quasi-experimental studies (16 controlled group studies, 29 single-subject designs). All (k = 45/45) reported improvement on a primary outcome measure; most reported generalization (k = 34/43), maintenance (k = 34/39), or social validity (k = 17/19) of treatment for at least one participant. The available evidence supports speech-language intervention for persons with PPA; however, treatment for PPAOS awaits systematic investigation. Implications and limitations of the evidence and the review are discussed.
原发性进行性失语症 (PPA) 和原发性进行性构音障碍 (PPAOS) 是神经退行性综合征,其特征是语言或言语逐渐下降。越来越多的研究调查了针对 PPA/PPAOS 的言语语言干预措施。有必要对治疗证据进行更新的系统评估,以提供最佳临床实践并指导未来的治疗研究。我们系统地回顾了针对该人群的言语治疗的行为治疗证据。审查的文章发表在同行评议的期刊上,截止日期为 2021 年 5 月 31 日。我们使用美国言语语言听力协会 (ASHA) 证据水平的修改版、评估点系统、额外的报告质量和内部/外部有效性项目,以及适当的单个案例实验设计量表或物理治疗证据数据库- PsycBITE 随机和非随机对照试验的评级量表,评估证据水平、报告质量和偏倚风险。结果使用定量总结和叙述性综述进行综合。共有 103 项研究报告了 626 名 PPA 患者的治疗结果;没有研究使用 PPAOS 的诊断标签。大多数研究评估了单词检索的干预措施。45 项实验和准实验研究(16 项对照研究,29 项单病例设计)提供了最高质量的证据。所有(k=45/45)报告了主要结局测量指标的改善;大多数报告了治疗的泛化(k=34/43)、维持(k=34/39)或社会有效性(k=17/19)至少对一名参与者。现有证据支持对 PPA 患者进行言语语言干预;然而,对 PPAOS 的治疗仍有待系统研究。讨论了证据和综述的意义和局限性。